indole-2-carboxylic acid has been researched along with benzo(b)thiophene-2-carboxylic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arasappan, A; Beyer, BM; McCoy, MA; Njoroge, FG; Senior, MM; Wang, YS; Wyss, DF | 1 |
| Burke, JP; Camper, D; Chauder, BA; Daniels, RN; Fesik, SW; Friberg, A; Garcia-Barrantes, PM; Lee, T; Olejniczak, ET; Vigil, D; Zhao, B | 1 |
| Boersma, YL; Dekker, FJ; Dömling, ASS; Eleftheriadis, N; Wójcik, M; Zwinderman, MRH | 1 |
3 other study(ies) available for indole-2-carboxylic acid and benzo(b)thiophene-2-carboxylic acid
| Article | Year |
|---|---|
Non-peptidic small-molecule inhibitors of the single-chain hepatitis C virus NS3 protease/NS4A cofactor complex discovered by structure-based NMR screening.
Topics: Anilides; Benzene Derivatives; Binding Sites; Carrier Proteins; Databases, Factual; Enzyme Inhibitors; Hepacivirus; Indoles; Intracellular Signaling Peptides and Proteins; Magnetic Resonance Spectroscopy; Models, Molecular; Structure-Activity Relationship; Viral Nonstructural Proteins; Viral Proteins | 2004 |
Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design.
Topics: Antineoplastic Agents; bcl-X Protein; Crystallography, X-Ray; Databases, Factual; Drug Design; Humans; Indoles; Ligands; Magnetic Resonance Spectroscopy; Molecular Docking Simulation; Molecular Structure; Myeloid Cell Leukemia Sequence 1 Protein; Protein Binding; Proto-Oncogene Proteins c-bcl-2; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Identification of potential antivirulence agents by substitution-oriented screening for inhibitors of Streptococcus pyogenes sortase A.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Cysteine Endopeptidases; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Kinetics; Microbial Sensitivity Tests; Molecular Structure; Streptococcus pyogenes; Structure-Activity Relationship | 2019 |